vigil sanofi - Search News

News

Sanofi buys Vigil Neuroscience for $470m

Vigil Neuroscience Stock Triples as Drugmaker Agrees to Acquisition by Sanofi

Key Takeaways Vigil Neuroscience shares more than tripled Thursday after the company reached a deal to be acquired by Sanofi.French pharmaceutical giant Sanofi agreed to pay $8.00 per share in cash at closing,

· 3d · on MSN

Sanofi to buy Vigil Neuroscience in $470M deal (update)

· 2d

Vigil Neuroscience to be acquired by Sanofi for $8.00 per share

Fierce Biotech3d

Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race

Sanofi’s 11 months watching over Vigil Neuroscience have led to a $470 million buyout. | Sanofi’s 11 months watching over ...

PharmTech1d

Sanofi to Acquire Vigil Neuroscience to Expand Neurodegenerative Disease Pipeline

Sanofi is acquiring Vigil Neuroscience, a biotech firm focused on novel neurodegenerative disease therapies, to boost its ...

MedCity News2d

Sanofi’s Neuro Pipeline Expands to Alzheimer’s With $470M Vigil Neuroscience Acquisition

Sanofi is expanding its neuroscience drug pipeline through the $470 million acquisition(Opens in a new window) of Vigil Neuroscience, a clinical-stage biotech with a ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

News

Sanofi buys Vigil Neuroscience for $470m

Trending now